FDA recall F-0672-2025 · Class I · Terminated
Wangzhine branded Hot Pot Sauce; Net Weight: 160 Grams, 5.64OZ; 36 units/case; UPC# 6907592001375
- Codes:
- Best before: 2026-07-02
- Quantity:
- 3650 cases
On March 4, 2025, Liaoning Cheng Da (USA) Inc began a Class I recall covering 2 products. Reason: (Imported) Hot Pot Sauce contains undeclared allergens (Wheat and Soy).
2 products from Liaoning Cheng Da (USA), listed below. The first: Wangzhine branded Hot Pot Sauce.
(Imported) Hot Pot Sauce contains undeclared allergens (Wheat and Soy)
(Imported) Hot Pot Sauce (SPICY) contains undeclared allergens (Wheat and Soy)
California.
Distribution as reported to FDA: The firm has distributed to 5 direct account consignees here in California.
Class I: the FDA uses this class for a situation where there is a reasonable probability that eating the product will cause serious health problems or death.
Status: Terminated. FDA has closed the recall. Closed November 25, 2025.
Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact Liaoning Cheng Da (USA) Inc.
FDA recall F-0672-2025 · Class I · Terminated
Wangzhine branded Hot Pot Sauce; Net Weight: 160 Grams, 5.64OZ; 36 units/case; UPC# 6907592001375
FDA recall F-0673-2025 · Class I · Terminated
Wangzhine branded Hot Pot Sauce (SPICY); Net Weight: 160 Grams, 5.64OZ; 36 units/case; UPC# 6907592001382
USDA FSIS · Nov 14, 2026
Product Contamination
Arkansas, Louisiana, Mississippi, Oklahoma, Tennessee, Texas · Public health alert
USDA FSIS · Nov 6, 2026
Unreported Allergens
Nationwide · Public health alert
FDA · Nov 4, 2026
Products are recalled due to potential undeclared wheat gluten
3 products · Nationwide · Ongoing
FDA · Nov 4, 2026
Salmonella
48 states · Ongoing
Broccoli seeds potentially contaminated with Salmonella
Ongoing
FDA · Nov 4, 2026
JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.
Nationwide · Ongoing